Dr. Choti received his MD degree at Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins.  Dr. Choti is the principal or co-investigator for a variety of clinical and preclinical studies examining new approaches for the treatment of liver, pancreatic, and colorectal cancer. He is the PI of NSABP C-11, an Intergroup Phase III study for patients with resectable hepatic colorectal metastases.

Dr. Choti serves on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He currently serves as Chair of the NCI-CTEP Hepatobiliary Task Force and the Director of the NCCN Neuroendocrine Tumor database. He serves on the American College of Surgeons’ Commission on Cancer, the GI committees of NSABP and ACOSOG, and the Colorectal Cancer and Neuroendocrine Tumors Guidelines Panels of NCCN.

In addition to clinical research, Dr. Choti also maintains an active laboratory effort in the use of robotics and computer assistance to surgically treat gastrointestinal malignancies. This work has been funded through a series of NIH grants and industry collaborations.  He also has a strong interest in molecular genetics and biomarkers in gastrointestinal cancer. He has more than 200 peer-reviewed publications.

Education and patient advocacy has also been important to Dr. Choti. He serves on the medical advisory boards for several foundations related to GI cancer. He has directed educational symposia and served on program committees for ASCO, AHPBA, among others. In addition, he is the Director of the SSO Surgical Oncology Fellowship Program at Johns Hopkins.